Guanbin Gao is a senior research scientist in the in vivo gene engineering team at AstraZeneca, where they work on developing therapeutic genome editing tools to benefit patients. Their current focus includes validating the efficacy and exploring side effects of these therapeutics in humanized animal models. Previously, Guanbin completed a postdoctoral research position at the Karolinska Institutet and earned a PhD in Molecular Biology from The Hong Kong University of Science and Technology. They also possess extensive experience in mitochondrial-related metabolic diseases, contributing to disease model generation and exploring genetic and pharmaceutical interventions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices